Thermo Fisher Scientific Raises FY2024 Outlook: Adj EPS $21.40-$22.02 ($20.95-22.00 Prior) vs $21.53 Est; Sales $42.3B-$43.3B ($42.1B-43.3B Prior) vs $42.83B Est
Portfolio Pulse from Benzinga Newsdesk
Thermo Fisher Scientific has updated its FY2024 financial outlook, increasing both its revenue and adjusted EPS guidance. The new revenue forecast is between $42.3 billion and $43.3 billion, up from the previous range of $42.1 billion to $43.3 billion. The adjusted EPS guidance has been raised to $21.40-$22.02, from the earlier forecast of $20.95-$22.00. These adjustments reflect the company's stronger operational performance.
April 24, 2024 | 10:03 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Thermo Fisher Scientific raises its FY2024 revenue and adjusted EPS guidance, indicating a stronger operational performance than previously anticipated.
Thermo Fisher's upward revision of both revenue and EPS guidance for FY2024 suggests a positive outlook on its operational performance and financial health. This is likely to instill confidence among investors, potentially leading to a short-term increase in stock price as the market reacts to the positive news. The adjustments are significant as they surpass previous estimates, indicating that the company is performing better than expected.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100